What is the dosage of Qsymia?

Qsymia is available in 4 dosages, including 7.5-46 mg 24 HR XR Cap, 11.25-69 mg 24 HR XR Cap, 15-92 mg 24 HR XR Cap and 3.75-23 mg 24 HR XR Cap

What is Qsymia mechanism of action?

Qsymia mechanism of action is Cytochrome P450 2C19 Inhibitors or Cytochrome P450 3A4 Inducers

Qsymia Prescribing & Dosing Schedule

Q: What does Qsymia treat?

Qsymia treats Bipolar Disorder, Epilepsies, Partial, Epilepsy, Tonic-Clonic, Obesity, Pain, Spasms, Infantile and Lennox Gastaut Syndrome

Q: What is Qsymia made of?

Qsymia contains phentermine / topiramate which is a Sympathomimetic Amine Anorectic

Q: How is Qsymia administered?

Qsymia is administered as a Oral Pill

Dosage & Administration

* Take orally once daily in morning. Avoid administration in evening to prevent insomnia ( 2.2).
* Recommended starting dosage is 3.75 mg/23 mg (phentermine mg/topiramate mg) daily for 14 days; then increase to 7.5 mg/46 mg daily ( 2.2).
* Escalate dosage based on weight loss in adults or BMI reduction in pediatric patients. See the Full Prescribing Information for details regarding discontinuation or dosage escalation ( 2.2).
* Gradually discontinue 15 mg/92 mg dosage to prevent possible seizure ( 2.3).
* Do not exceed 7.5 mg/46 mg dosage for patients with moderate or severe renal impairment or patients with moderate hepatic impairment ( 2.4, 2.5).

Get Your Patient on Qsymia

See your patient's specific prior authorization requirements including coverage restrictions and step therapies

Or select your Insurance from the list below:

Qsymia Prescribing Information

Report Adverse Event

Qsymia Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

Coverage Authorization Appeals

Complete Letter of Medical Necessity

Benefits investigation

Medvantx Prescription Form

Qsymia Preferred Pharmacy

Pharmacy List

Qsymia Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form